Knockdown of CDCP1 blocks tumor metastasis and peritoneal dissemination in vivo, without significantly affecting cell proliferation10, suggesting CDCP1 is a potential target to disrupt the progression of cancer. This evidence concerns the gene CDCP1 and neoplasm.